In primary NSCLC tumors, fibronectin-mediated β1-integrin activation also results in PI3K/Akt and FAK activation to drive pro-proliferative and pro-invasive signaling (69–71). This evidence concerns the gene FN1 and non-small cell lung carcinoma.